Rebecca Mashaw

News

FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test

06/28/2024

Rebecca Mashaw ;

The device can provide results in an hour from a fingertip blood test.

The device can provide results...

06/28/2024

Gastroenterology

FDA Alert

FDA Approves Risankizumab for Ulcerative Colitis

06/20/2024

Rebecca Mashaw ;

The approval makes risankizumab the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and Crohn's disease.

The approval makes risankizumab...

06/20/2024

Advances in Inflammatory Bowel Disease Network

FDA Alert

Elafibranor Receives Accelerated FDA Approval for PBC

06/14/2024

Rebecca Mashaw ;

The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.

The first-in-class PPAR is the...

06/14/2024

Gastroenterology

Conference Coverage

The Promise and Progress of New Approaches to Treating the Inflammatory Bowel Diseases

10/25/2022

Rebecca Mashaw ;

Bruce E. Sands, MD, MS, FACG, gave the J. Edward Berk Distinguished Lecture at the American College of Gastroenterology Scientific Meeting on October 25, reviewing the progress of therapies for inflammatory bowel disease (IBD) and emerging...

Bruce E. Sands, MD, MS, FACG,...

10/25/2022

Advances in Inflammatory Bowel Disease Network

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

September 18 ⁠–⁠ September 20

September 21 ⁠–⁠ September 22

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

See Full Calendar

Rebecca Mashaw

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products